Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Hong Chen"'
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-16 (2022)
Abstract Background Attenuated Oxaliplatin efficacy is a challenge in treating colorectal cancer (CRC) patients, contributory to the failure in chemotherapy and the risks in relapse and metastasis. However, the mechanism of Oxaliplatin de-efficacy du
Externí odkaz:
https://doaj.org/article/f8332733b68f45cb94db67874dfab007
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Although evidence has revealed that miR-200a-3p is involved in the malignant progression of various tumors, the regulatory mechanism of miR-200a-3p in the development of cervical cancer (CC) cells with different HPV statuses remai
Externí odkaz:
https://doaj.org/article/53b9f23b7dee4f218cf8dc1d6291529c
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Androgen deprivation therapy (ADT) combined with docetaxel chemotherapy is the standard treatment for metastatic castration-resistant prostate cancer (mCRPC) patients. However, mCRPC patients are mainly frail elderly men, constant
Externí odkaz:
https://doaj.org/article/9c051b9daa4e45508ce01c68fd491580
Autor:
Che, Kaijun1,2 (AUTHOR), Hong, Chen1 (AUTHOR), He, Yanqing3 (AUTHOR), Peng, Duanyang1 (AUTHOR), Zeng, Zhimin1,4,5 (AUTHOR) 2zm@163.com, Liu, Anwen1,4,5 (AUTHOR) awliu666@163.com
Publikováno v:
BMC Cancer. 11/6/2023, Vol. 23 Issue 1, p1-8. 8p.
Autor:
Chen-Hua Yan, Xiao-Dong Mo, Yi-Fei Cheng, Xiao-Su Zhao, Xiao-Jun Huang, Yu Wang, Yu-Hong Chen, Huan Chen, Xiao-Hui Zhang, Wei Han, Ya-Zhen Qin, Juan-Juan Wen, Lan-Ping Xu, Dao-Xing Deng, Feng-Rong Wang, Kai-Yan Liu, Jing-Zhi Wang
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Cancer
BMC Cancer
Background Sequential monitoring of Wilms’ tumor gene 1 (WT1) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) could predict relapse in adult acute myeloid leukemia (AML). However, the prognostic role of WT1 in pediatric AML aft
Autor:
Xiaoyang Zhang, Shu Chen LiuHuang, Zhong-Fa Lu, Runyi Jiang, Yu-Hong Chen, Xian-Jie Wu, Jia-Li Xu, Piaopiao Xu, Xiao-Shuang Yang, Yu-Xin Ding, Jing Jing
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-16 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-16 (2021)
Background Previous studies reported cutaneous melanoma in head and neck (HNM) differed from those in other regions (body melanoma, BM). Individualized tools to predict the survival of patients with HNM or BM remain insufficient. We aimed at comparin
CA19–9 decrease and survival according to platelet level in patients with advanced pancreatic cancer
Publikováno v:
BMC Cancer
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
Background CA19–9 decrease during treatment has been associated with superior survival of pancreatic cancer in several studies. The evidence to show the correlation of high platelet level with inferior survival is insufficient in pancreatic cancer.
Autor:
Oluwaseun Adebayo Bamodu, Tse-Hung Huang, Peter Mu Hsin Chang, Jia Hong Chen, Tsu Yi Chao, Wen Chien Huang
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-13 (2019)
BMC Cancer
BMC Cancer
Background Metastasis is a leading cause of breast cancer mortality. The induction of epithelial-to-mesenchymal transition (EMT) and complex oncogenic signaling is a vital step in the evolution of highly metastatic and therapeutically-intractable bre
Autor:
Long-Hua Guo, Yi-Long Wu, Zhi-Hong Chen, Xu-Chao Zhang, Hong-Hong Yan, Jin-Ji Yang, Chong-Rui Xu, Qing Zhou, Zhi Xie, Feng Li, Wei-Bang Guo, Jian Su
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
BMC Cancer
BMC Cancer
Background Intratumoral epidermal growth factor receptor (EGFR) mutational heterogeneity is yet controversial in non-small cell lung cancer (NSCLC) patients. Single-cell analysis provides the genetic profile of single cancer cells and an in-depth und
Autor:
Xing-Hua Che1, Hong Chen1, Zhen-Ming Xu2, Chao Shang3, Kai-Lai Sun1, Wei-Neng Fu1 wnfu@mail.cmu.edu.cn
Publikováno v:
BMC Cancer. 2010, Vol. 10, p306-315. 10p.